The ACE2 downregulation, as a result of SARS-CoV-2 binding, enhances the AT1R axis [38] likely to be associated with IR [39, 40], but also with inflammation [41] and severe outcomes of COVID-19. The gene discussed is AGTR1; the disease is COVID-19.